152 related articles for article (PubMed ID: 4476950)
21. The hemagglutination-inhibition assay for thrombopoietin.
McDonald TP
Blood; 1973 Feb; 41(2):219-33. PubMed ID: 4707614
[No Abstract] [Full Text] [Related]
22. Indirect hemagglutination test for chlamydial antibodies.
Lewis VJ; Thacker WL; Engelman HM
Appl Microbiol; 1972 Jul; 24(1):22-5. PubMed ID: 4626906
[TBL] [Abstract][Full Text] [Related]
23. The use of platelet serotonin release as a sensitive method for detecting anti-platelet antibodies and a plasma anti-platelet factor in patients with idiopathic thrombocytopenic purpura.
Hirschman RJ; Shulman NR
Br J Haematol; 1973 Jun; 24(6):793-802. PubMed ID: 4736742
[No Abstract] [Full Text] [Related]
24. The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. I. Studies of immunoglobulins of different types.
Pfueller SL; Lüscher EF
J Immunol; 1972 Sep; 109(3):517-25. PubMed ID: 5066345
[No Abstract] [Full Text] [Related]
25. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response.
Dixon R; Rosse W; Ebbert L
N Engl J Med; 1975 Jan; 292(5):230-6. PubMed ID: 1078594
[TBL] [Abstract][Full Text] [Related]
26. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.
Karpatkin S; Nardi MA
J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345
[TBL] [Abstract][Full Text] [Related]
27. Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura.
Adner MM; Fisch GR; Starobin SG; Aster RH
N Engl J Med; 1969 Jan; 280(5):244-7. PubMed ID: 5812507
[No Abstract] [Full Text] [Related]
28. Antibodies in human sera to stratum corneum.
Krogh HK
Int Arch Allergy Appl Immunol; 1969; 36(4):415-26. PubMed ID: 5349689
[No Abstract] [Full Text] [Related]
29. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect.
Nilsson UR; Miller ME; Wyman S
J Immunol; 1974 Mar; 112(3):1164-76. PubMed ID: 4204560
[No Abstract] [Full Text] [Related]
30. Post-transfusion purpura: immunologic aspects and therapy.
Abramson N; Eisenberg PD; Aster RH
N Engl J Med; 1974 Nov; 291(22):1163-6. PubMed ID: 4472486
[No Abstract] [Full Text] [Related]
31. Functional heterogeneity of antibody to penicilloyl coated erythrocytes.
Watson KC
Immunology; 1971 Mar; 20(3):381-90. PubMed ID: 5551359
[TBL] [Abstract][Full Text] [Related]
32. Interaction between erythrocyte membrane proteins and complement components. II. The identification and peptide composition of complement components C3 and C4 desorbed from erythrocyte membranes.
Bhakdi S; Knüfermann H; Fischer H; Wallach DF
Biochim Biophys Acta; 1974 Dec; 373(2):295-307. PubMed ID: 4473230
[No Abstract] [Full Text] [Related]
33. The zeta potential and hemagglutination with Rh antibodies. A physiochemical explanation.
Pollack W; Reckel RP
Int Arch Allergy Appl Immunol; 1970; 38(5):482-96. PubMed ID: 4986153
[No Abstract] [Full Text] [Related]
34. Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura.
Zucker-Franklin D; Karpatkin S
N Engl J Med; 1977 Sep; 297(10):517-23. PubMed ID: 560627
[TBL] [Abstract][Full Text] [Related]
35. Serologic specificity of platelets.
Milgrom F; Campbell WA; Witebsky E
Vox Sang; 1968 Dec; 15(6):418-26. PubMed ID: 4192916
[No Abstract] [Full Text] [Related]
36. Observations on the rare phenomenon of anti-A prozone and the non-specific blocking of haemagglutination due to C1 complement fixation by IgG anti-A antibodies.
Voak D
Vox Sang; 1972; 22(5):408-19. PubMed ID: 5032415
[No Abstract] [Full Text] [Related]
37. Aspirin-induced thrombocytopenia on an immune basis.
Garg SK; Sarker CR
Am J Med Sci; 1974 Feb; 267(2):129-32. PubMed ID: 4856606
[No Abstract] [Full Text] [Related]
38. Leucocyte mobilizing factor: a new biological activity derived from the third component of complement.
Rother K
Eur J Immunol; 1972 Dec; 2(6):550-8. PubMed ID: 4266011
[No Abstract] [Full Text] [Related]
39. The problem of platelet autoantibodies. I. Evaluation of the platelet factor 3 availability test for their detection.
Mueller-Eckhardt C; Mersch-Baumert K
Vox Sang; 1977 Oct; 33(4):221-33. PubMed ID: 331683
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies of anti-A agglutinins from various snails of the genus Helix (Helix pomatia and Helix aspersa).
Ishiyama I; Dietz W; Uhlenbruck G
Comp Biochem Physiol B; 1973 Feb; 44(2):529-47. PubMed ID: 4196846
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
